Skip to main content

White Paper: What Does Poor Quality Cost?

The cost of quality. A simple statement and yet few companies in the pharmaceutical manufacturing industry are paying close enough attention to this concept. This white paper highlights the financial gain a company can get from focusing its efforts and resources on prevention of defects in its processes. It also provides recommendations for you to identify and tackle the cost of poor quality.

How NSF Can Help You

Get in touch to find out how we can help you and your business thrive.

What’s New with NSF

  • iNADO Partners with NSF to Support Members and Athletes

    May 27, 2026
    iNADO is pleased to welcome NSF’s expertise and experience in support of its members and the athletes they serve
    Read the Story
  • NSF Ends UK’s Three-Year Testing Gap with REG 31 Testing Designation

    May 20, 2026
    NSF’s Oakdale laboratory becomes the UK’s sole facility offering comprehensive BS 6920 and REG 31 testing, closing a critical drinking water safety gap.
    Read the Story
  • NSF Annual Review and Impact Report 2025 Now Live

    April 20, 2026
    NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
    Read the Story
  • Visit NSF at Making Pharma 2026

    April 10, 2026
    Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.
    Read the Story